Biomea Fusion to Present at J.P. Morgan Healthcare Conference
I'm PortAI, I can summarize articles.
Biomea Fusion Inc., a clinical-stage biopharmaceutical company, will present at the 44th Annual J.P. Morgan Healthcare Conference. Interim CEO Mick Hitchcock, Ph.D., will present on January 14, 2026, from 5:15 PM to 5:55 PM Pacific Time. The conference runs from January 12-15, 2026, and Biomea’s management will also participate in one-on-one meetings. A live audio webcast will be available on the company’s website.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments